Roche’s virtual event following ASH 2021
Agenda
Welcome
Hematology Franchise Overview
Review of Key Clinical Data Presented at ASH: Hemlibra, mosun, glofit, cevostamab
Presentation of POLARIX data
Q&A
Karl Mahler, Head of Investor Relations
Peter Ahnesorg, Franchise Head Hematology
Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development
Franck Morschhauser, MD, PhD, Professor of Hematology, University of Lille; President of LYSA, LYSARC

Please register to access the replay*

*Privacy notice

Live Webinar Replay

Roche has hosted a virtual event on Wednesday, 15 December 2021.

Investors
Past IR Events
View more Events

Downloads

Related links